Zhou Q, Wang X, Li R, Wang C, et al. Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis. J Gastroenterol 2022 Jul 11. pii: 10.1007/s00535-022-01895.
PMID: 35816221